Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events: The BE ACTIVE Randomized Controlled Trial

Author:

Fanaroff Alexander C.12345ORCID,Patel Mitesh S.6ORCID,Chokshi Neel145ORCID,Coratti Samantha3,Farraday David3,Norton Laurie37ORCID,Rareshide Charles3ORCID,Zhu Jingsan137,Klaiman Tamar13ORCID,Szymczak Julia E.8ORCID,Russell Louise B.347,Small Dylan S.49,Volpp Kevin G.M.13479ORCID

Affiliation:

1. Department of Medicine, Perelman School of Medicine, (A.C.F., N.C., J.Z., T.K., K.G.M.V.), University of Pennsylvania, Philadelphia.

2. Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center (A.C.F.), University of Pennsylvania, Philadelphia.

3. Penn Center for Health Incentives and Behavioral Economics (AC.F., S.C., D.F., L.N., C.R., J.Z., T.K., L.B.R., K.G.M.V.), University of Pennsylvania, Philadelphia.

4. Leonard Davis Institute of Health Economics (A.C.F., N.C., L.B.R., D.S.S., K.G.M.V.), University of Pennsylvania, Philadelphia.

5. Penn Center for Digital Cardiology (A.C.F., N.C.), University of Pennsylvania, Philadelphia.

6. Ascension Health, St. Louis, MO (M.S.P.).

7. Department of Medical Ethics and Health Policy (L.N., J.Z., L.B.R., K.G.M.V.), University of Pennsylvania, Philadelphia.

8. Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City (J.E.S.).

9. The Wharton School (D.S.S., K.G.M.V.), University of Pennsylvania, Philadelphia.

Abstract

BACKGROUND: Physical activity is associated with a lower risk of major adverse cardiovascular events, but few individuals achieve guideline-recommended levels of physical activity. Strategies informed by behavioral economics increase physical activity, but their longer-term effectiveness is uncertain. We sought to determine the effect of behaviorally designed gamification, loss-framed financial incentives, or their combination on physical activity compared with attention control over 12-month intervention and 6-month postintervention follow-up periods. METHODS: Between May 2019 and January 2024, participants with clinical atherosclerotic cardiovascular disease or a 10-year risk of myocardial infarction, stroke, or cardiovascular death of ≥7.5% by the Pooled Cohort equation were enrolled in a pragmatic randomized clinical trial. Participants received a wearable device to track daily steps, established a baseline, selected a step goal increase, and were randomly assigned to control (n=151), behaviorally designed gamification (n=304), loss-framed financial incentives (n=302), or gamification+financial incentives (n=305). The primary outcome of the trial was the change in mean daily steps from baseline through the 12-month intervention period. RESULTS: A total of 1062 patients (mean±SD age, 67±8; 61% female; 31% non-White) were enrolled. Compared with control subjects, participants had significantly greater increases in mean daily steps from baseline during the 12-month intervention in the gamification arm (adjusted difference, 538.0 [95% CI, 186.2–889.9]; P =0.0027), financial incentives arm (adjusted difference, 491.8 [95% CI, 139.6–844.1]; P =0.0062), and gamification+financial incentives arm (adjusted difference, 868.0 [95% CI, 516.3–1219.7]; P <0.0001). During the 6-month follow-up, physical activity remained significantly greater in the gamification+financial incentives arm than in the control arm (adjusted difference, 576.2 [95% CI, 198.5–954]; P =0.0028), but it was not significantly greater in the gamification (adjusted difference, 459.8 [95% CI, 82.0–837.6]; P =0.0171) or financial incentives (adjusted difference, 327.9 [95% CI, −50.2 to 706]; P =0.09) arms after adjustment for multiple comparisons. CONCLUSIONS: Behaviorally designed gamification, loss-framed financial incentives, and the combination of both increased physical activity compared with control over a 12-month intervention period, with the largest effect in gamification+financial incentives. These interventions could be a useful component of strategies to reduce cardiovascular risk in high-risk patients. REGISTRATION: URL: https://clinicaltrials.gov ; Unique Identifier: NCT03911141.

Funder

HHS | NIH | National Heart, Lung, and Blood Institute

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3